| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
261 |
232 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
172 |
140 |
$4K |
| 0004A |
|
66 |
66 |
$680.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
170 |
138 |
$583.32 |
| 0002A |
|
43 |
43 |
$167.60 |
| 0124A |
|
31 |
31 |
$147.01 |
| 36415 |
Collection of venous blood by venipuncture |
15 |
13 |
$106.00 |
| 0064A |
|
19 |
19 |
$89.20 |
| 0001A |
|
45 |
45 |
$69.20 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29 |
28 |
$68.86 |
| 0134A |
|
28 |
28 |
$61.00 |
| Q3014 |
Telehealth originating site facility fee |
21 |
20 |
$59.61 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
29 |
23 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
25 |
23 |
$0.00 |
| A0425 |
Ground mileage, per statute mile |
13 |
12 |
$0.00 |